In Alternative Views, Hedgeweek® goes behind closed doors with those in the know to get the latest on hedge funds. Today, we speak to Vincent Ijaouane, Founder and CIO of Vigama Capital, whose European equity long/short fund has generated strong
Separately managed accounts have become emerging managers’ favoured capital-raising tool. Managers who underestimate the operational weight do so at their peril.
Allocator enthusiasm for hedge funds has rarely looked stronger in the past few years. In our latest Hedgeweek® survey of alternatives allocators this March, more than 90%named hedge funds as the strategy they are most optimistic about in 2026 –
In Alternative Views, Hedgeweek® goes behind closed doors with those in the know to get the latest on hedge funds. In this episode we speak to Salvatore Cordaro, CEO of Investcorp-Tages.
In Alternative Views, Hedgeweek® goes behind closed doors with those in the know to get the latest on hedge funds. Today we speak to the CEO of Moreton Capital Partners, Les Finemore, who has recently launched a new commodities based
The Iran conflict has sent crude prices surging, split hedge fund performance and reignited the debate over commodities as a strategic allocation. Hedgeweek examines what the disruption means for the sector.
PivotalPath’s analysis shows managed futures and macro commodities thriving in high oil environments, but allocators heading into 2026 had other priorities.
In Alternative Views, Hedgeweek® goes behind closed doors with those in the know to get the latest on hedge funds. In celebration of International Women’s Day, we speak to Teresa Isele, CEO of Rhenman & Partners, a healthcare focused Swedish
Something shifted in the hedge fund industry’s collective mindset over the past 12 months. According to the Hedgeweek® Q1 2026 Global Outlook Survey of more than 100 hedge fund managers, 41% now rank AI integration into their investment processes as
In Alternative Views, Hedgeweek® goes behind closed doors with those in the know to get the latest on hedge funds. In this episode we speak to Marton Peter Price, co-founder of EverestQuant, a quantitative hedge fund which applies scientific research
